Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Avadel Pharmaceuticals Revenue 2010-2024 | AVDL

Avadel Pharmaceuticals revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  
Avadel Pharmaceuticals Annual Revenue
(Millions of US $)
2023 $28
2022 $
2021 $
2020 $22
2019 $59
2018 $103
2017 $173
2016 $150
2015 $173
2014 $15
2013 $4
2012 $26
2011 $33
2010 $37
2009 $42
Avadel Pharmaceuticals Quarterly Revenue
(Millions of US $)
2024-03-31 $27
2023-12-31 $19
2023-09-30 $7
2023-06-30 $1
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30 $10
2020-03-31 $12
2019-12-31 $11
2019-09-30 $14
2019-06-30 $18
2019-03-31 $16
2018-12-31 $21
2018-09-30 $20
2018-06-30 $29
2018-03-31 $33
2017-12-31 $35
2017-09-30 $40
2017-06-30 $46
2017-03-31 $53
2016-12-31 $43
2016-09-30 $32
2016-06-30 $39
2016-03-31 $36
2015-12-31 $43
2015-09-30 $47
2015-06-30 $49
2015-03-31 $33
2014-12-31 $3
2014-09-30 $7
2014-06-30 $8
2014-03-31 $9
2013-12-31 $6
2013-09-30 $6
2013-06-30 $6
2013-03-31 $5
2012-12-31 $7
2012-09-30 $5
2012-06-30 $6
2012-03-31 $7
2011-12-31 $9
2011-09-30 $10
2011-06-30 $7
2011-03-31 $7
2010-12-31 $13
2010-09-30 $8
2010-06-30 $8
2010-03-31 $8
2009-12-31 $11
2009-09-30 $10
2009-06-30 $10
2009-03-31 $12
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.434B $0.028B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.717B 31.19
Chugai Pharmaceutical (CHGCY) Japan $52.344B 23.40
Takeda Pharmaceutical (TAK) Japan $42.314B 8.57
Merck (MKGAF) Germany $21.381B 20.17
Astellas Pharma (ALPMY) Japan $17.916B 28.29
Sandoz Group AG (SDZNY) Switzerland $15.072B 0.00
Shionogi (SGIOY) Japan $14.270B 12.80
Neurocrine Biosciences (NBIX) United States $14.055B 38.47
United Therapeutics (UTHR) United States $11.801B 12.58
Catalent (CTLT) United States $10.131B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.681B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.131B 7.84
Revolution Medicines (RVMD) United States $6.179B 0.00
Ionis Pharmaceuticals (IONS) United States $5.761B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.410B 0.00
Alpine Immune Sciences (ALPN) United States $4.250B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.892B 0.00
Summit Therapeutics (SMMT) United States $3.355B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.063B 0.00
Corcept Therapeutics (CORT) United States $2.769B 25.09
Indivior (INDV) United States $2.464B 11.68
PTC Therapeutics (PTCT) United States $2.381B 0.00
Dyne Therapeutics (DYN) United States $2.268B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.027B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.986B 11.35
NewAmsterdam Pharma (NAMS) Netherlands $1.951B 0.00
Ardelyx (ARDX) United States $1.876B 0.00
Evotec AG (EVO) Germany $1.868B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.849B 17.99
Fusion Pharmaceuticals (FUSN) Canada $1.819B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 27.90
Soleno Therapeutics (SLNO) United States $1.592B 0.00
Xencor (XNCR) United States $1.451B 0.00
Pacira BioSciences (PCRX) United States $1.390B 13.21
4D Molecular Therapeutics (FDMT) United States $1.312B 0.00
Collegium Pharmaceutical (COLL) United States $1.238B 7.41
Enliven Therapeutics (ELVN) United States $1.123B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.102B 0.00
Cronos Group (CRON) Canada $1.089B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.055B 16.44
Centessa Pharmaceuticals (CNTA) United Kingdom $0.962B 0.00
Cassava Sciences (SAVA) United States $0.913B 0.00
Ocular Therapeutix (OCUL) United States $0.905B 0.00
USANA Health Sciences (USNA) United States $0.882B 14.43
ARS Pharmaceuticals (SPRY) United States $0.853B 0.00
Relay Therapeutics (RLAY) United States $0.838B 0.00
Sage Therapeutics (SAGE) United States $0.743B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.738B 0.00
Savara (SVRA) United States $0.701B 0.00
Silence Therapeutics (SLN) United Kingdom $0.687B 0.00
Lyell Immunopharma (LYEL) United States $0.683B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.606B 0.00
ProKidney (PROK) United States $0.599B 0.00
Exscientia (EXAI) United Kingdom $0.598B 0.00
Siga Technologies (SIGA) United States $0.551B 7.05
Altimmune (ALT) United States $0.547B 0.00
OmniAb (OABI) United States $0.535B 0.00
Verve Therapeutics (VERV) United States $0.534B 0.00
KalVista Pharmaceuticals (KALV) United States $0.510B 0.00
Larimar Therapeutics (LRMR) United States $0.501B 0.00
Lexeo Therapeutics (LXEO) United States $0.478B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.467B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.460B 0.00
Heron Therapeutics (HRTX) United States $0.443B 0.00
Korro Bio (KRRO) United States $0.440B 0.00
Bioventus (BVS) United States $0.432B 16.55
Tourmaline Bio (TRML) United States $0.404B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Harrow (HROW) United States $0.364B 0.00
Black Diamond Therapeutics (BDTX) United States $0.355B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.333B 0.00
Nanobiotix S.A (NBTX) France $0.314B 0.00
Organogenesis (ORGO) United States $0.301B 57.00
Aquestive Therapeutics (AQST) United States $0.300B 0.00
Fractyl Health (GUTS) United States $0.298B 0.00
Nektar Therapeutics (NKTR) United States $0.294B 0.00
Nature's Sunshine Products (NATR) United States $0.293B 18.59
Xeris Biopharma Holdings (XERS) United States $0.279B 0.00
Akebia Therapeutics (AKBA) United States $0.278B 0.00
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.274B 0.00
Pyxis Oncology (PYXS) United States $0.266B 0.00
Metagenomi (MGX) United States $0.258B 0.00
Adherex Technologies (FENC) United States $0.257B 0.00
Foghorn Therapeutics (FHTX) United States $0.253B 0.00
Eliem Therapeutics (ELYM) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Avita Medical (RCEL) United States $0.225B 0.00
Conduit Pharmaceuticals (CDT) United States $0.224B 0.00
Zevra Therapeutics (ZVRA) United States $0.218B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Galectin Therapeutics (GALT) United States $0.201B 0.00
Century Therapeutics (IPSC) United States $0.197B 0.00
Telomir Pharmaceuticals (TELO) United States $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.184B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Prelude Therapeutics (PRLD) United States $0.171B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Incannex Healthcare (IXHL) Australia $0.162B 0.00
Achieve Life Sciences (ACHV) Canada $0.155B 0.00
Cardiol Therapeutics (CRDL) Canada $0.151B 0.00
Regulus Therapeutics (RGLS) United States $0.147B 0.00
CytoDyn (CYDY) United States $0.144B 0.00
Context Therapeutics (CNTX) United States $0.137B 0.00
Elite Pharmaceuticals (ELTP) United States $0.135B 12.63
VAXART, INC (VXRT) United States $0.129B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.129B 8.59
OptiNose (OPTN) United States $0.127B 0.00
Karyopharm Therapeutics (KPTI) United States $0.126B 0.00
FibroGen (FGEN) United States $0.121B 0.00
Relmada Therapeutics (RLMD) United States $0.115B 0.00
Citius Pharmaceuticals (CTXR) United States $0.112B 0.00
PMV Pharmaceuticals (PMVP) United States $0.108B 0.00
Inotiv (NOTV) United States $0.107B 0.00
Assertio Holdings (ASRT) United States $0.100B 4.57
Vivani Medical (VANI) United States $0.095B 0.00
AlloVir (ALVR) United States $0.094B 0.00
ProPhase Labs (PRPH) United States $0.089B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Jaguar Animal Health (JAGX) United States $0.085B 0.00
Tempest Therapeutics (TPST) United States $0.077B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.071B 1.00
Journey Medical (DERM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.063B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.062B 0.00
Protara Therapeutics (TARA) United States $0.061B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
BioLineRx (BLRX) Israel $0.055B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
JanOne (JAN) United States $0.037B 0.00
Nutriband (NTRB) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.035B 0.00
DURECT (DRRX) United States $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.025B 0.00
Lyra Therapeutics (LYRA) United States $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 0.78
BioVie (BIVI) United States $0.020B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Talphera (TLPH) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.31
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.76